JoVE Search Results: Cardiac Muscle

Impact
Papers
Jobs
Conferences

Name	Impact ?	Papers	Institution	Country	Funding
Oldfors, Anders	232.3	2	University of Gothenburg	Sweden	-
Olson, Eric N	201.8	5	University of Texas Southwestern Medical Center	USA	$16,085,906.00
Kumar, Ashok	162.8	20	University of Louisville School of Medicine	USA	$10,722,593.00
Duan, Dongsheng	154.3	23	One Hospital Drive	USA	$5,534,786.00
Spiegelman, Bruce M	138.2	2	Harvard Medical School	USA	$23,638,733.00
Rudnicki, Michael A	134.7	6	Ottawa Hospital Research Institute	Canada	$1,359,734.00
Tisdale, Michael J	114.3	5	Aston University	UK	-
Sandri, Marco	106.7	10	University of Padova	Italy	-
Blau, Helen M	84.3	2	Stanford University School of Medicine	USA	$10,449,331.00
Lynch, Gordon S	77.7	8	The University of Melbourne	Australia	-
Guttridge, Denis C	73.2	5	The Ohio State University	USA	$13,081,742.00
Krook, Anna	70.2	2	Karolinska University Hospital	Sweden	-
Zierath, J R	69.7	4	Karolinska Institutet	Sweden	-
Molkentin, Jeffery D	65.3	4	Cincinnati Children's Hospital Medical Center	USA	$9,242,818.00
Glass, David J	64.8	5	Novartis Institutes for Biomedical Research	USA	-
Han, H Q	64.8	1	Departments of Metabolic Disorders and Protein Science, Amgen Research, Thousand Oaks, CA 91320	USA	-
Sweeney, H Lee	63.3	12	University of Pennsylvania School of Medicine	USA	$26,536,029.00
Kambadur, Ravi	62.3	5	Nanyang Technological University	Singapore	-
Delafontaine, Patrice	61.9	9	Tulane University School of Medicine	USA	$4,071,380.00
Rodeheffer, Matthew S	58.4	1	Yale University School of Medicine	USA	$1,272,482.00
Mitch, William E	57.9	5	Baylor College of Medicine	USA	$57,582.00
van Loon, Luc J C	57.6	8	Maastricht University Medical Centre+	Netherlands	-
Huard, Johnny	56.9	8	University of Pittsburgh Medical Center	USA	$2,457,029.00
Oudit, Gavin Y	55	9	University of Alberta	Canada	-
Adams, Christopher M	54.6	4	The University of Iowa	USA	$1,453,302.00
Wasserman, David H	54.5	3	Vanderbilt Univ. School of Medicine	USA	$14,199,826.00
Wood, Matthew J A	53.5	9	University of Oxford	UK	-
Keller, Charles	53.1	1	Oregon Health & Science University	USA	$2,876,041.00
Braun, Thomas	50.8	1	Max-Planck-Institute for Heart and Lung Research	Germany	$1,083,479.00
Rando, Thomas A	50.8	1	Massachusetts General Hospital	USA	$13,058,340.00
Zoll, Joffrey	49	2	University of Strasbourg	France	-
Handschin, Christoph	47.3	4	University of Basel	Switzerland	-
Cohn, Ronald D	47	3	Johns Hopkins University School of Medicine	USA	$2,961,548.00
Pedersen, Bente K	44.9	4	University of Copenhagen	Denmark	-
Zhu, Dahai	44.6	6	Peking Union Medical College	China	-
Hasselgren, Per-Olof	44.5	13	Harvard Medical School	USA	$1,829,814.00
Tein, Ingrid	44.3	1	Hospital for Sick Children	Canada	-
Kemp, Paul R	43.5	3	Imperial College London	UK	-
Goodyear, Laurie J	43	3	Research Division, Joslin Diabetes Center, Boston, Massachusetts	USA	$6,466,027.00
Leinwand, Leslie A	41.9	3	University of Colorado at Boulder	USA	-
Wagner, Kathryn R	41.7	5	The Johns Hopkins School of Medicine	USA	$4,079,866.00
Tidball, James G	41.6	7	University of California Los Angeles	USA	$4,790,782.00
Pavlath, Grace K	41.6	3	Emory University	USA	$7,594,939.00
Gregorevic, Paul	41	2	Baker IDI Heart and Diabetes Institute	Australia	-
Laing, Nigel G	41	1	The University of Western Australia	Australia	-
Nagaraju, Kanneboyina	40.9	5	Center for Genetic Medicine Research.	N/A	$1,678,084.00
Kunkel, Louis M	40.7	6	Harvard Medical School	USA	$15,755,848.00
Marks, Andrew R	40.6	3	Department of Physiology and Cellular Biophysics and the Clyde andHelenWu Center for Molecular Cardiology, New York, NY	USA	-
Clemens, Paula R	40.5	8	University of Pittsburgh	USA	$2,297,838.00
Langen, Ramon C J	39.2	7	Maastricht University Medical Centre + (MUMC+)	Netherlands	-

Name	Institution	Date	Impact	Publication
Oldfors, Anders	University of Gothenburg	04/01/2010	53.29	The New England journal of medicine Glycogenin-1 deficiency and inactivated priming of glycogen synthesis. Abstract
Lynch, Gordon S	The University of Melbourne	04/04/2012	36.28	Nature Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Abstract
Sandri, Marco	University of Padova	09/29/2013	35.53	Nature genetics BMP signaling controls muscle mass. Abstract
Spiegelman, Bruce M	Harvard Medical School	12/10/2012	32.40	Cell A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Abstract
Blau, Helen M	Stanford University School of Medicine	12/09/2010	32.40	Cell Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Abstract
Olson, Eric N	University of Texas Southwestern Medical Center	10/04/2010	32.40	Cell Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Abstract
Tisdale, Michael J	Aston University	08/20/2010	32.40	Cell Reversing cachexia. Abstract
Han, H Q	Departments of Metabolic Disorders and Protein Science, Amgen Research, Thousand Oaks, CA 91320	08/20/2010	32.40	Cell Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Abstract
Rudnicki, Michael A	Ottawa Hospital Research Institute	01/10/2013	26.86	Physiological reviews Satellite cells and the muscle stem cell niche. Abstract
Keller, Charles	Oregon Health & Science University	10/19/2012	26.56	Cancer cell The not-so-skinny on muscle cancer. Abstract
Olson, Eric N	University of Texas Southwestern Medical Center	10/19/2012	26.56	Cancer cell A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. Abstract
Braun, Thomas	Max-Planck-Institute for Heart and Lung Research	08/08/2013	25.42	Cell stem cell Myf5-positive satellite cells contribute to Pax7-dependent long-term maintenance of adult muscle stem cells. Abstract
Rando, Thomas A	Massachusetts General Hospital	05/07/2012	25.42	Cell stem cell Tissue-specific stem cells: lessons from the skeletal muscle satellite cell. Abstract
Marks, Andrew R	Columbia University College of Physicians and Surgeons	02/08/2009	22.46	Nature medicine Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Abstract
Krook, Anna	Karolinska University Hospital	10/06/2009	20.22	Pharmacological reviews Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Abstract
Blau, Helen M	Stanford University School of Medicine	07/07/2013	19.48	Nature cell biology Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy. Abstract
Rudnicki, Michael A	Ottawa Hospital Research Institute	12/18/2011	19.48	Nature cell biology Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle. Abstract
Rodeheffer, Matthew S	Yale University School of Medicine	01/17/2010	19.48	Nature cell biology Tipping the scale: muscle versus fat. Abstract
Oudit, Gavin Y	University of Alberta	08/02/2010	14.73	Circulation Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Abstract
Molkentin, Jeffery D	Cincinnati Children's Hospital Medical Center	01/11/2010	14.73	Circulation Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Abstract
Glass, David J	Novartis Institutes for Biomedical Research	10/25/2011	14.03	Developmental cell The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. Abstract
Pavlath, Grace K	Emory University	11/20/2009	14.03	Developmental cell MOR23 promotes muscle regeneration and regulates cell adhesion and migration. Abstract
Mitch, William E	Baylor College of Medicine	09/09/2013	13.66	Cell metabolism Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass. Abstract
Zierath, Juleen R	Karolinska Institutet	02/11/2013	13.66	Cell metabolism Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Abstract
Kambadur, Ravi	Nanyang Technological University	11/12/2012	13.66	Cell metabolism The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Abstract
Guttridge, Denis C	The Ohio State University	07/12/2012	13.66	Cell metabolism Cancer cachexia: mediators, signaling, and metabolic pathways. Abstract
Zierath, Juleen R	Karolinska Institutet	03/12/2012	13.66	Cell metabolism Acute exercise remodels promoter methylation in human skeletal muscle. Abstract
Adams, Christopher M	The University of Iowa	06/06/2011	13.66	Cell metabolism mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Abstract
Spiegelman, Bruce M	Harvard Medical School	02/02/2011	13.66	Cell metabolism The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex. Abstract
Sandri, Marco	University of Padova	11/30/2009	13.66	Cell metabolism Autophagy is required to maintain muscle mass. Abstract
Guttridge, Denis C	The Ohio State University	01/31/2014	13.06	The Journal of clinical investigation NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. Abstract
Olson, Eric N	University of Texas Southwestern Medical Center	05/01/2012	13.06	The Journal of clinical investigation microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. Abstract
Olson, Eric N	University of Texas Southwestern Medical Center	09/13/2011	13.06	The Journal of clinical investigation Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy. Abstract
Molkentin, Jeffery D	Howard Hughes Medical Institute	04/07/2011	13.06	The Journal of clinical investigation Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. Abstract
Duan, Dongsheng	The University of Missouri	02/23/2009	13.06	The Journal of clinical investigation Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. Abstract
Olson, Eric N	University of Texas Southwestern Medical Center	03/09/2009	12.89	Current opinion in cell biology MicroRNA control of muscle development and disease. Abstract
Rudnicki, Michael A	Ottawa Hospital Research Institute	08/31/2012	12.35	Trends in cell biology Wnt signaling in myogenesis. Abstract
Tein, Ingrid	Hospital for Sick Children	06/02/2010	11.08	Annals of neurology Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise. Abstract
Pavlath, Grace K	Emory University	10/06/2011	10.92	Trends in pharmacological sciences RNA-binding proteins and gene regulation in myogenesis. Abstract
Zoll, Joffrey	University of Strasbourg	07/20/2011	10.47	European heart journal Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1. Abstract
Cohn, Ronald D	Johns Hopkins University School of Medicine	11/19/2012	10.33	EMBO molecular medicine Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. Abstract
Gregorevic, Paul	Baker IDI Heart and Diabetes Institute	10/21/2013	10.26	The Journal of cell biology The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. Abstract
Kunkel, Louis M	Harvard Medical School	05/14/2013	10.26	The Journal of cell biology The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. Abstract
Gregorevic, Paul	Baker IDI Heart and Diabetes Institute	06/18/2012	10.26	The Journal of cell biology Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. Abstract
Kumar, Ashok	University of Louisville School of Medicine	12/28/2010	10.26	The Journal of cell biology Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. Abstract
Sandri, Marco	University of Padova	10/05/2010	10.26	The Journal of cell biology JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy. Abstract
Kumar, Ashok	University of Louisville School of Medicine	03/23/2010	10.26	The Journal of cell biology The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. Abstract
Laing, Nigel G	The University of Western Australia	05/25/2009	10.26	The Journal of cell biology Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. Abstract
Handschin, Christoph	University of Basel	11/25/2013	9.81	Proceedings of the National Academy of Sciences of the United States of America The transcriptional coactivator PGC-1α is dispensable for chronic overload-induced skeletal muscle hypertrophy and metabolic remodeling. Abstract
Rudnicki, Michael A	Ottawa Hospital Research Institute	09/24/2013	9.81	Proceedings of the National Academy of Sciences of the United States of America Pax7 is critical for the normal function of satellite cells in adult skeletal muscle. Abstract
Duan, Dongsheng	The University of Missouri	11/26/2012	9.81	Proceedings of the National Academy of Sciences of the United States of America α2 and α3 helices of dystrophin R16 and R17 frame a microdomain in the α1 helix of dystrophin R17 for neuronal NOS binding. Abstract
Rudnicki, Michael A	Ottawa Hospital Research Institute	11/26/2012	9.81	Proceedings of the National Academy of Sciences of the United States of America Wnt7a treatment ameliorates muscular dystrophy. Abstract
Goodyear, Laurie J	Research Division, Joslin Diabetes Center, Boston, Massachusetts	08/16/2010	9.81	Proceedings of the National Academy of Sciences of the United States of America Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. Abstract
Leinwand, Leslie A	University of Colorado at Boulder	12/28/2009	9.81	Proceedings of the National Academy of Sciences of the United States of America Functional diversity among a family of human skeletal muscle myosin motors. Abstract
Mitch, William E	Baylor College of Medicine	01/07/2010	9.66	Journal of the American Society of Nephrology : JASN Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. Abstract
Mitch, William E	Baylor College of Medicine	01/21/2009	9.66	Journal of the American Society of Nephrology : JASN IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. Abstract
Zierath, Juleen R	Karolinska Institutet	10/05/2012	8.29	Diabetes Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Abstract
Wasserman, David H	Vanderbilt Univ. School of Medicine	09/21/2012	8.29	Diabetes Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Abstract
Wasserman, David H	Vanderbilt Univ. School of Medicine	01/28/2011	8.29	Diabetes Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice. Abstract
Goodyear, Laurie J	Research Division, Joslin Diabetes Center, Boston, Massachusetts	07/09/2010	8.29	Diabetes Kinetics of contraction-induced GLUT4 translocation in skeletal muscle fibers from living mice. Abstract
Goodyear, Laurie J	Research Division, Joslin Diabetes Center, Boston, Massachusetts	03/18/2010	8.29	Diabetes TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle. Abstract
Kambadur, Ravi	Nanyang Technological University	04/19/2011	8.19	Cell research Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts. Abstract
Pedersen, Bente K	University of Copenhagen	03/09/2009	8.12	Trends in endocrinology and metabolism: TEM ROS and myokines promote muscle adaptation to exercise. Abstract
Wood, Matthew J A	University of Oxford	08/14/2013	8.03	Nucleic acids research Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Abstract
Huard, Johnny	University of Pittsburgh Medical Center	01/12/2009	7.87	Arthritis and rheumatism Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Abstract
Leinwand, Leslie A	University of Colorado at Boulder	12/16/2010	7.86	Cancer research Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Abstract
Cohn, Ronald D	Johns Hopkins University School of Medicine	05/12/2011	7.80	Science translational medicine Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Abstract
Nagaraju, Kanneboyina	Center for Genetic Medicine Research.	12/23/2013	7.64	Human molecular genetics Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle. Abstract
Kunkel, Louis M	Children's Hospital Boston and Harvard Medical School	11/13/2013	7.64	Human molecular genetics Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling. Abstract
Kumar, Ashok	University of Louisville School of Medicine	10/24/2013	7.64	Human molecular genetics Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy. Abstract
Duan, Dongsheng	The University of Missouri	05/15/2013	7.64	Human molecular genetics Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Abstract
Duan, Dongsheng	The University of Missouri	03/03/2013	7.64	Human molecular genetics Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy. Abstract
Kumar, Ashok	University of Louisville School of Medicine	08/16/2011	7.64	Human molecular genetics Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice. Abstract
Tidball, James G	University of California Los Angeles	11/30/2010	7.64	Human molecular genetics Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Abstract
Wood, Matthew J A	University of Oxford	11/09/2010	7.64	Human molecular genetics Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Abstract
Wood, Matthew J A	University of Oxford	08/18/2009	7.64	Human molecular genetics A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice. Abstract
Tidball, James G	University of California Los Angeles	06/19/2009	7.64	Human molecular genetics Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. Abstract
Wagner, Kathryn R	The Johns Hopkins School of Medicine	05/28/2009	7.64	Human molecular genetics Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice. Abstract
Kumar, Ashok	University of Louisville School of Medicine	04/28/2009	7.64	Human molecular genetics Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Abstract
Duan, Dongsheng	The University of Missouri	01/08/2009	7.64	Human molecular genetics Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Abstract
Tidball, James G	University of California Los Angeles	11/07/2008	7.64	Human molecular genetics Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Abstract
Kumar, Ashok	University of Louisville School of Medicine	08/16/2011	7.45	Autophagy TRAF6 coordinates the activation of autophagy and ubiquitin-proteasome systems in atrophying skeletal muscle. Abstract
Sandri, Marco	University of Padova	02/06/2010	7.45	Autophagy Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles. Abstract
Nagaraju, Kanneboyina	Research Center for Genetic Medicine, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010	01/07/2013	7.40	Molecular & cellular proteomics : MCP Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Abstract
Rudnicki, Michael A	Ottawa Hospital Research Institute	11/15/2013	7.36	EMBO reports Cellular dynamics in the muscle satellite cell niche. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	12/06/2011	6.87	Molecular therapy : the journal of the American Society of Gene Therapy Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping. Abstract
Duan, Dongsheng	The University of Missouri	08/02/2011	6.87	Molecular therapy : the journal of the American Society of Gene Therapy AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice. Abstract
Wood, Matthew Ja	Tianjin Medical University	04/19/2011	6.87	Molecular therapy : the journal of the American Society of Gene Therapy Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice. Abstract
Wood, Matthew Ja	Tianjin Medical University	08/10/2010	6.87	Molecular therapy : the journal of the American Society of Gene Therapy Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO. Abstract
Wood, Matthew J A	University of Oxford	01/12/2010	6.87	Molecular therapy : the journal of the American Society of Gene Therapy Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse. Abstract
Huard, Johnny	University of Pittsburgh	07/14/2009	6.87	Molecular therapy : the journal of the American Society of Gene Therapy Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Abstract
Duan, Dongsheng	The University of Missouri	12/09/2008	6.87	Molecular therapy : the journal of the American Society of Gene Therapy Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Abstract
Kemp, Paul R	Imperial College London	06/28/2013	6.84	Thorax Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Abstract
Kemp, Paul R	Imperial College London	10/13/2011	6.84	Thorax Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Abstract
Zhu, Dalong	Drum Tower hospital affiliated to Nanjing University Medical School	12/21/2013	6.81	Diabetologia Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription. Abstract
Handschin, C	University of Basel	04/02/2011	6.81	Diabetologia Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β) improves skeletal muscle mitochondrial function and insulin sensitivity. Abstract
Zierath, J R	Karolinska Institutet	03/27/2010	6.81	Diabetologia Nitric oxide increases cyclic GMP levels, AMP-activated protein kinase (AMPK)alpha1-specific activity and glucose transport in human skeletal muscle. Abstract
Mitch, William E	Baylor College of Medicine	03/20/2013	6.61	Kidney international Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease. Abstract
Langen, Ramon C J	Maastricht University Medical Centre + (MUMC+)	09/05/2010	6.57	Cellular and molecular life sciences : CMLS Palmitate-induced skeletal muscle insulin resistance does not require NF-κB activation. Abstract
Langen, R C J	Maastricht University Medical Centre	08/08/2010	6.57	Cellular and molecular life sciences : CMLS Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β. Abstract
Oldfors, Anders	University of Gothenburg	10/26/2009	6.37	Journal of medical genetics Unexpected myopathy associated with a mutation in MYBPC3 and misplacement of the cardiac myosin binding protein C. Abstract
Duan, Dongsheng	The University of Missouri	10/28/2010	6.32	The Journal of pathology Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice. Abstract
Oudit, Gavin Y	University of Alberta	06/15/2012	6.29	Circulation. Heart failure Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction. Abstract
Oudit, Gavin Y	University of Alberta	06/15/2009	6.29	Circulation. Heart failure Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Abstract
Handschin, Christoph	University of Basel	11/21/2013	6.27	Seminars in immunopathology Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology. Abstract
Oudit, Gavin Y	University of Alberta	04/16/2012	6.21	Hypertension Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice. Abstract
Delafontaine, Patrice	Tulane University School of Medicine	08/15/2011	6.21	Hypertension Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting. Abstract
Oudit, Gavin Y	University of Alberta	12/28/2010	6.21	Hypertension Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Abstract
van Loon, Luc J C	Maastricht University Medical Centre+	05/21/2009	6.17	Ageing research reviews The impact of sarcopenia and exercise training on skeletal muscle satellite cells. Abstract
Wagner, Kathryn R	The Johns Hopkins School of Medicine	06/08/2012	6.11	Journal of cell science Inhibition of myostatin reverses muscle fibrosis through apoptosis. Abstract
Duan, Dongsheng	The University of Missouri	05/18/2010	6.11	Journal of cell science Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. Abstract
Guttridge, Denis C	The Ohio State University	05/30/2011	6.00	Current topics in developmental biology NF-κB signaling in skeletal muscle health and disease. Abstract
Glass, David J	Novartis Institutes for Biomedical Research	11/18/2013	5.81	Critical reviews in biochemistry and molecular biology Signaling pathways controlling skeletal muscle mass. Abstract
Tidball, James G	University of California Los Angeles	10/17/2011	5.79	Journal of immunology (Baltimore, Md. : 1950) IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. Abstract
Kumar, Ashok	University of Louisville School of Medicine	08/01/2011	5.79	Journal of immunology (Baltimore, Md. : 1950) Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy. Abstract
Kumar, Ashok	University of Louisville School of Medicine	12/10/2013	5.71	FASEB journal : official publication of the Federation of American Societies for Experimental Biology Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program. Abstract
Huard, Johnny	University of Pittsburgh	05/23/2013	5.71	FASEB journal : official publication of the Federation of American Societies for Experimental Biology RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice. Abstract
Pavlath, Grace K	Emory University	12/14/2010	5.71	FASEB journal : official publication of the Federation of American Societies for Experimental Biology Sca-1 is negatively regulated by TGF-beta1 in myogenic cells. Abstract
Lynch, Gordon S	The University of Melbourne	07/12/2010	5.71	FASEB journal : official publication of the Federation of American Societies for Experimental Biology Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. Abstract
Glass, David J	Novartis Institutes for Biomedical Research	12/02/2013	5.53	Molecular and cellular biology An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Abstract
Kumar, Ashok	University of Louisville School of Medicine	10/01/2012	5.53	Molecular and cellular biology Reciprocal interaction between TRAF6 and notch signaling regulates adult myofiber regeneration upon injury. Abstract
Kumar, Ashok	University of Louisville School of Medicine	01/30/2012	5.53	Molecular and cellular biology The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Abstract
Leinwand, Leslie A	University of Colorado at Boulder	08/30/2011	5.44	International journal of cancer. Journal international du cancer Myosin heavy chain is not selectively decreased in murine cancer cachexia. Abstract
Clemens, Paula R	University of Pittsburgh	05/23/2011	5.40	Neurobiology of disease Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology. Abstract
Guttridge, Denis C	The Ohio State University	06/27/2009	5.36	Cell cycle (Georgetown, Tex.) microRNAs: novel components in a muscle gene regulatory network. Abstract
Zhu, D	Chinese Academy of Sciences	02/14/2013	5.33	Cell death & disease Myostatin induces mitochondrial metabolic alteration and typical apoptosis in cancer cells. Abstract
Oudit, Gavin Y	University of Alberta	12/09/2013	5.17	Journal of molecular and cellular cardiology Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. Abstract
Duan, Dongsheng	The University of Missouri	05/12/2012	5.17	Journal of molecular and cellular cardiology AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. Abstract
Tisdale, M J	Aston University	06/14/2011	5.04	British journal of cancer Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF). Abstract
van Loon, Luc J C	Maastricht University Medical Centre+	02/05/2009	4.98	The journals of gerontology. Series A, Biological sciences and medical sciences Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men. Abstract
Sandri, Marco	University of Padova	12/26/2012	4.94	Disease models & mechanisms Cellular and molecular mechanisms of muscle atrophy. Abstract
Huard, Johnny	University of Pittsburgh Medical Center	05/31/2011	4.89	The American journal of pathology Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Abstract
Kumar, Ashok	University of Louisville School of Medicine	08/19/2010	4.89	The American journal of pathology Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice. Abstract
Kumar, Ashok	University of Louisville School of Medicine	05/14/2010	4.89	The American journal of pathology Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice. Abstract
Lynch, Gordon S	The University of Melbourne	04/02/2010	4.89	The American journal of pathology Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice. Abstract
Lynch, Gordon S	The University of Melbourne	12/03/2009	4.89	The American journal of pathology Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Abstract
Molkentin, Jeffery D	Howard Hughes Medical Institute	10/15/2009	4.89	The American journal of pathology Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy. Abstract
Delafontaine, Patrice	Tulane University School of Medicine	07/06/2013	4.77	The Journal of biological chemistry Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration. Abstract
Adams, Christopher M	The University of Iowa	06/12/2012	4.77	The Journal of biological chemistry Stress-induced skeletal muscle Gadd45a expression reprograms myonuclei and causes muscle atrophy. Abstract
Kambadur, Ravi	Nanyang Technological University	02/23/2012	4.77	The Journal of biological chemistry Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity. Abstract
Handschin, Christoph	University of Basel	08/17/2010	4.77	The Journal of biological chemistry Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. Abstract
Kumar, Ashok	University of Louisville School of Medicine	12/11/2008	4.77	The Journal of biological chemistry Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. Abstract
Krook, Anna	Karolinska University Hospital	10/08/2013	4.75	American journal of physiology. Endocrinology and metabolism Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Abstract
Adams, Christopher M	The University of Iowa	08/13/2013	4.75	American journal of physiology. Endocrinology and metabolism Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4. Abstract
Kambadur, Ravi	Nanyang Technological University	04/24/2012	4.75	American journal of physiology. Endocrinology and metabolism Lack of Smad3 signaling leads to impaired skeletal muscle regeneration. Abstract
Glass, David J	Novartis Institutes for Biomedical Research	11/02/2010	4.75	American journal of physiology. Endocrinology and metabolism Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement. Abstract
Hasselgren, Per-Olof	Harvard Medical School	07/20/2010	4.75	American journal of physiology. Endocrinology and metabolism Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle. Abstract
Wasserman, David H	Vanderbilt Univ. School of Medicine	10/07/2008	4.75	American journal of physiology. Endocrinology and metabolism Four grams of glucose. Abstract
Marks, Andrew R	Department of Physiology and Cellular Biophysics and the Clyde andHelenWu Center for Molecular Cardiology, New York, NY	10/15/2012	4.72	The Journal of physiology Stress-induced increase in skeletal muscle force requires protein kinase A phosphorylation of the ryanodine receptor. Abstract
Tidball, James G	University of California Los Angeles	02/23/2009	4.72	The Journal of physiology Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy. Abstract
Wagner, Kathryn R	The Johns Hopkins School of Medicine	03/11/2009	4.70	Experimental neurology A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Abstract
Wood, Matthew J A	University of Oxford	07/13/2011	4.67	Journal of molecular medicine (Berlin, Germany) The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy. Abstract
Kumar, Ashok	University of Louisville School of Medicine	10/09/2009	4.67	Journal of molecular medicine (Berlin, Germany) Therapeutic targeting of signaling pathways in muscular dystrophy. Abstract
Mitch, William E	Baylor College of Medicine	07/16/2013	4.63	The international journal of biochemistry & cell biology Muscle wasting from kidney failure-a model for catabolic conditions. Abstract
Delafontaine, Patrice	Tulane University School of Medicine	06/13/2013	4.63	The international journal of biochemistry & cell biology Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Abstract
Kumar, Ashok	University of Louisville School of Medicine	05/11/2013	4.63	The international journal of biochemistry & cell biology Wasting mechanisms in muscular dystrophy. Abstract
Sandri, Marco	University of Padova	05/07/2013	4.63	The international journal of biochemistry & cell biology Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Abstract
Zhu, Dahai	Peking Union Medical College	09/29/2010	4.63	The international journal of biochemistry & cell biology Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells. Abstract
Hasselgren, Per-Olof	Harvard Medical School	01/13/2010	4.63	The international journal of biochemistry & cell biology Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism. Abstract
Kambadur, Ravi	Nanyang Technological University	09/29/2011	4.54	Molecular endocrinology (Baltimore, Md.) Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. Abstract
Van Loon, Luc J C	Maastricht University Medical Centre+	11/19/2012	4.48	Medicine and science in sports and exercise Reduced satellite cell numbers with spinal cord injury and aging in humans. Abstract
Pedersen, Bente Klarlund	University of Copenhagen	02/23/2012	4.48	Medicine and science in sports and exercise Muscular interleukin-6 and its role as an energy sensor. Abstract
Kumar, A	University of Louisville School of Medicine	01/16/2012	4.48	Current molecular medicine The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting. Abstract
Marks, Andrew R	Columbia University College of Physicians and Surgeons	02/24/2010	4.46	Pflügers Archiv : European journal of physiology Ryanodine receptor channelopathies. Abstract
Delafontaine, Patrice	Tulane University School of Medicine	01/10/2012	4.46	Endocrinology Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus. Abstract
Tisdale, Michael J	Aston University	08/11/2010	4.46	Endocrinology Mechanism of attenuation of skeletal muscle atrophy by zinc-alpha2-glycoprotein. Abstract
Lynch, Gordon S	The University of Melbourne	10/14/2009	4.38	Current opinion in clinical nutrition and metabolic care The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders. Abstract
Wagner, Kathryn R	The Johns Hopkins School of Medicine	09/30/2011	4.31	Current opinion in rheumatology Regeneration versus fibrosis in skeletal muscle. Abstract
Langen, Ramon C	Top Institute Food & Nutrition-TIFN	05/31/2012	4.30	Molecular nutrition & food research Leucine induces myofibrillar protein accretion in cultured skeletal muscle through mTOR dependent and -independent control of myosin heavy chain mRNA levels. Abstract
Langen, Ramon C J	Maastricht University Medical Centre + (MUMC+)	12/02/2010	4.30	Molecular nutrition & food research Trans-10, cis-12 conjugated linoleic acid inhibits skeletal muscle differentiation and GLUT4 expression independently from NF-κB activation. Abstract
Duan, Dongsheng	The University of Missouri	10/24/2011	4.22	Human gene therapy Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	08/30/2011	4.22	Human gene therapy Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	12/14/2010	4.22	Human gene therapy Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage. Abstract
Duan, Dongsheng	The University of Missouri	11/06/2009	4.22	Human gene therapy Systemic Trans-splicing adeno-associated viral delivery efficiently transduces the heart of adult mdx mouse, a model for duchenne muscular dystrophy. Abstract
Kumar, Ashok	University of Louisville School of Medicine	08/15/2013	4.09	PloS one Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice. Abstract
Hasselgren, Per-Olof	Harvard Medical School	03/21/2013	4.09	PloS one PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting. Abstract
Cohn, Ronald D	Johns Hopkins University School of Medicine	11/14/2012	4.09	PloS one Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrels. Abstract
Adams, Christopher M	The University of Iowa	06/20/2012	4.09	PloS one Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. Abstract
Nagaraju, Kanneboyina	Research Center for Genetic Medicine, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010	04/03/2012	4.09	PloS one Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse. Abstract
Delafontaine, Patrice	Tulane University School of Medicine	01/20/2012	4.09	PloS one Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	01/11/2012	4.09	PloS one Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse. Abstract
Tidball, James G	University of California Los Angeles	10/07/2011	4.09	PloS one Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	09/13/2011	4.09	PloS one Myostatin is elevated in congenital heart disease and after mechanical unloading. Abstract
Duan, Dongsheng	The University of Missouri	06/30/2011	4.09	PloS one iNOS ablation does not improve specific force of the extensor digitorum longus muscle in dystrophin-deficient mdx4cv mice. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	06/22/2011	4.09	PloS one Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice. Abstract
Duan, Dongsheng	The University of Missouri	12/20/2010	4.09	PloS one Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice. Abstract
Kumar, Ashok	University of Louisville School of Medicine	10/12/2010	4.09	PloS one Tumor necrosis factor-α regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. Abstract
Guttridge, Denis C	The Ohio State University	08/30/2010	4.09	PloS one TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy. Abstract
Tidball, James G	University of California Los Angeles	05/21/2010	4.09	PloS one Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	04/19/2010	4.09	PloS one Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	02/11/2010	4.09	PloS one Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice. Abstract
Nagaraju, Kanneboyina	Research Center for Genetic Medicine, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010	01/29/2010	4.09	PloS one Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse. Abstract
Kumar, Ashok	University of Louisville School of Medicine	01/19/2010	4.09	PloS one Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice. Abstract
Zhu, Dahai	Peking Union Medical College	02/22/2009	4.07	BMC genomics Systematic identification of genes involved in divergent skeletal muscle growth rates of broiler and layer chickens. Abstract
Tisdale, M J	Aston University	01/13/2010	4.06	Cellular signalling Mechanism of activation of dsRNA-dependent protein kinase (PKR) in muscle atrophy. Abstract
van Loon, Luc J C	Maastricht University Medical Centre+	04/23/2014	3.95	Age (Dordrecht, Netherlands) Satellite cells in human skeletal muscle; from birth to old age. Abstract
Kumar, Ashok	University of Louisville School of Medicine	03/06/2012	3.87	Journal of cellular physiology TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases. Abstract
Langen, Ramon C J	Maastricht University Medical Centre + (MUMC+)	04/25/2013	3.87	Current pharmaceutical design Regulation of skeletal muscle plasticity by glycogen synthase kinase-3β: a potential target for the treatment of muscle wasting. Abstract
Huard, Johnny	University of Pittsburgh School of Medicine	08/09/2011	3.79	The American journal of sports medicine Intramuscular transplantation of muscle-derived stem cells accelerates skeletal muscle healing after contusion injury via enhancement of angiogenesis. Abstract
Sandri, Marco	University of Padova	04/17/2013	3.79	The FEBS journal Mechanisms regulating skeletal muscle growth and atrophy. Abstract
Zhu, Dahai	Chinese Academy of Sciences	12/15/2009	3.79	The FEBS journal The myostatin-induced E3 ubiquitin ligase RNF13 negatively regulates the proliferation of chicken myoblasts. Abstract
Clemens, Paula R	University of Pittsburgh	02/08/2013	3.76	Molecular medicine (Cambridge, Mass.) Adeno-associated virus serotype 8 (AAV8) delivery of recombinant A20 to skeletal muscle reduces pathological activation of nuclear factor (NF)-κB in muscle of mdx mice. Abstract
Clemens, Paula R	University of Pittsburgh	05/09/2012	3.76	Molecular medicine (Cambridge, Mass.) Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse. Abstract
Clemens, Paula R	University of Pittsburgh	05/20/2011	3.76	Molecular medicine (Cambridge, Mass.) Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle. Abstract
Duan, Dongsheng	The University of Missouri	08/29/2013	3.75	Journal of applied physiology (Bethesda, Md. : 1985) Alpha 7 integrin preserves the function of the extensor digitorum longus muscle in dystrophin-null mice. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	07/03/2013	3.75	Journal of applied physiology (Bethesda, Md. : 1985) Long-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouse. Abstract
Duan, Dongsheng	The University of Missouri	12/06/2012	3.75	Journal of applied physiology (Bethesda, Md. : 1985) Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice. Abstract
Duan, Dongsheng	The University of Missouri	03/17/2011	3.75	Journal of applied physiology (Bethesda, Md. : 1985) The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice. Abstract
Sweeney, H L	University of Pennsylvania	09/16/2010	3.75	Journal of applied physiology (Bethesda, Md. : 1985) Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice. Abstract
van Loon, Luc J C	Maastricht University Medical Centre+	02/17/2013	3.74	Experimental gerontology The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Abstract
Van Loon, Luc J C	Maastricht University Medical Centre+	11/08/2010	3.74	Journal of the American Geriatrics Society Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men. Abstract
Duan, D	University of Missouri	02/09/2012	3.71	Gene therapy Progress in gene therapy of dystrophic heart disease. Abstract
Clemens, P R	University of Pittsburgh School of Medicine	09/09/2010	3.71	Gene therapy Effects of irradiating adult mdx mice before full-length dystrophin cDNA transfer on host anti-dystrophin immunity. Abstract
Clemens, P R	University of Pittsburgh School of Medicine	06/10/2010	3.71	Gene therapy Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene. Abstract
Oudit, Gavin Y	University of Alberta	02/08/2013	3.71	American journal of physiology. Heart and circulatory physiology ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Abstract
Delafontaine, Patrice	Tulane University School of Medicine	03/12/2010	3.71	American journal of physiology. Heart and circulatory physiology IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. Abstract
Duan, Dongsheng	The University of Missouri	08/16/2010	3.64	Laboratory investigation; a journal of technical methods and pathology An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed. Abstract
Tisdale, Michael J	Aston University	08/28/2009	3.58	Experimental cell research Mechanism of attenuation of protein loss in murine C2C12 myotubes by D-myo-inositol 1,2,6-triphosphate. Abstract
Delafontaine, Patrick	Tulane University School of Medicine	08/26/2011	3.54	FEBS letters Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects. Abstract
Sandri, Marco	University of Padova	02/02/2010	3.54	FEBS letters Autophagy in skeletal muscle. Abstract
Langen, Ramon C J	Maastricht University Medical Centre + (MUMC+)	08/10/2011	3.54	American journal of physiology. Cell physiology Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy. Abstract
Sandri, Marco	University of Padova	01/20/2010	3.54	American journal of physiology. Cell physiology Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Abstract
Sandri, Marco	University of Padova	04/08/2009	3.54	American journal of physiology. Cell physiology Smad2 and 3 transcription factors control muscle mass in adulthood. Abstract
Glass, David J	Novartis Institutes for Biomedical Research	04/08/2009	3.54	American journal of physiology. Cell physiology Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Abstract
Duan, Dongsheng	The University of Missouri	08/11/2011	3.47	Journal of translational medicine SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice. Abstract
Langen, Ramon C J	Maastricht University Medical Centre + (MUMC+)	11/01/2013	3.36	Respiratory research Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy. Abstract
Lynch, Gordon S	The University of Melbourne	06/15/2011	3.34	American journal of physiology. Regulatory, integrative and comparative physiology Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	09/15/2010	3.34	American journal of physiology. Regulatory, integrative and comparative physiology Leupeptin-based inhibitors do not improve the mdx phenotype. Abstract
Hasselgren, Per-Olof	Harvard Medical School	06/10/2010	3.34	American journal of physiology. Regulatory, integrative and comparative physiology Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. Abstract
Huard, Johnny	University of Pittsburgh Medical Center	06/19/2013	3.27	The Journal of bone and joint surgery. American volume Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. Abstract
Oudit, Gavin Y	University of Alberta	06/29/2012	3.21	Experimental physiology Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats. Abstract
Pedersen, Bente Klarlund	University of Copenhagen	07/10/2009	3.21	Experimental physiology Glucose ingestion during endurance training in men attenuates expression of myokine receptor. Abstract
Clemens, Paula R	University of Pittsburgh	05/21/2010	3.21	Immunobiology Migration of dendritic cells from murine skeletal muscle. Abstract
Oudit, Gavin Y	University of Alberta	06/11/2012	3.20	Heart failure reviews Role of ACE2 in diastolic and systolic heart failure. Abstract
Clemens, Paula R	University of Pittsburgh	01/05/2011	3.13	Neuromuscular disorders : NMD Novel mutation in MYH7 gene associated with distal myopathy and cardiomyopathy. Abstract
Molkentin, Jeffery D	Howard Hughes Medical Institute	07/15/2010	3.13	Neuromuscular disorders : NMD Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice. Abstract
van Loon, L J C	Toxicology and Metabolism Maastricht University Medical Centre	12/12/2013	3.09	Acta physiologica (Oxford, England) Neuromuscular electrical stimulation prevents muscle disuse atrophy during leg immobilization in humans. Abstract
van Loon, L J C	Toxicology and Metabolism Maastricht University Medical Centre	12/05/2013	3.09	Acta physiologica (Oxford, England) Substantial skeletal muscle loss occurs during only 5 days of disuse. Abstract
Hasselgren, Per-Olof	Harvard Medical School	11/22/2008	3.03	Nutrition (Burbank, Los Angeles County, Calif.) Curcumin and muscle wasting: a new role for an old drug? Abstract
Hasselgren, Per-Olof	Harvard Medical School	04/17/2013	2.87	Journal of cellular biochemistry CaMKII activity is reduced in skeletal muscle during sepsis. Abstract
Hasselgren, Per-Olof	Harvard Medical School	06/09/2011	2.87	Journal of cellular biochemistry C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1. Abstract
Hasselgren, Per-Olof	Harvard Medical School	10/27/2010	2.87	Journal of cellular biochemistry Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle. Abstract
Hasselgren, Per-Olof	Harvard Medical School	10/26/2009	2.87	Journal of cellular biochemistry Experimental hyperthyroidism in rats increases the expression of the ubiquitin ligases atrogin-1 and MuRF1 and stimulates multiple proteolytic pathways in skeletal muscle. Abstract
Huard, Johnny	University of Pittsburgh	10/23/2012	2.81	Journal of orthopaedic research : official publication of the Orthopaedic Research Society Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities. Abstract
Pedersen, Bente Klarlund	University of Copenhagen	09/15/2010	2.79	Exercise immunology review Leukaemia inhibitory factor--an exercise-induced myokine. Abstract
Kunkel, Louis M	Harvard Medical School	12/29/2011	2.73	The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society β4 integrin marks interstitial myogenic progenitor cells in adult murine skeletal muscle. Abstract
Hasselgren, Per-Olof	Harvard Medical School	07/15/2013	2.66	Metabolism: clinical and experimental Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes. Abstract
Hasselgren, Per-Olof	Harvard Medical School	05/22/2012	2.66	Metabolism: clinical and experimental Acetylation and deacetylation--novel factors in muscle wasting. Abstract
Hasselgren, Per-Olof	Harvard Medical School	06/13/2012	2.48	Biochemical and biophysical research communications β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy. Abstract
Hasselgren, Per-Olof	Harvard Medical School	12/07/2011	2.48	Biochemical and biophysical research communications Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism. Abstract
Kemp, Paul R	Imperial College London	11/02/2011	2.48	Biochemical and biophysical research communications Myostatin induces autophagy in skeletal muscle in vitro. Abstract
Delafontaine, Patrice	Tulane University School of Medicine	05/06/2011	2.48	Biochemical and biophysical research communications Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. Abstract
Zhu, Dahai	Peking Union Medical College	07/30/2009	2.48	Biochemical and biophysical research communications Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin. Abstract
Wood, Matthew J A	University of Oxford	04/07/2010	2.48	The journal of gene medicine In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy. Abstract
Wood, Matthew J A	University of Oxford	07/17/2010	2.43	Peptides Identification of a novel muscle targeting peptide in mdx mice. Abstract
Wagner, Kathryn R	The Johns Hopkins School of Medicine	06/29/2013	2.37	Muscle & nerve Fast skeletal muscle troponin activator in the dy2J muscular dystrophy model. Abstract
Zoll, Joffrey	University of Strasbourg	08/21/2012	2.37	Muscle & nerve Mitochondria of trained skeletal muscle are protected from deleterious effects of statins. Abstract
Huard, Johnny	University of Pittsburgh Medical Center	05/29/2012	2.37	Muscle & nerve Timing of the administration of suramin treatment after muscle injury. Abstract
Duan, Dongsheng	One Hospital Drive	01/16/2012	2.37	Muscle & nerve Gender differences in contractile and passive properties of mdx extensor digitorum longus muscle. Abstract
Duan, Dongsheng	The University of Missouri	12/09/2010	2.37	Muscle & nerve Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction. Abstract
Sweeney, H Lee	University of Pennsylvania School of Medicine	10/26/2010	2.37	Muscle & nerve Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy. Abstract
Duan, Dongsheng	The University of Missouri	09/29/2010	2.37	Muscle & nerve Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. Abstract
Kunkel, Louis M	Children's Hospital Boston and Harvard Medical School	05/31/2010	2.37	Muscle & nerve Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy. Abstract
Kunkel, Louis M	Children's Hospital Boston and Harvard Medical School	09/22/2009	2.37	Muscle & nerve CXCR4 enhances engraftment of muscle progenitor cells. Abstract
Kunkel, Louis M	Children's Hospital Boston and Harvard Medical School	04/09/2009	2.37	Muscle & nerve Expression of synemin in the mouse spinal cord. Abstract
Nagaraju, Kanneboyina	Research Center for Genetic Medicine, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010	04/09/2009	2.37	Muscle & nerve Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Abstract
Lynch, Gordon S	The University of Melbourne	12/29/2011	2.26	Journal of inflammation (London, England) Ageing prolongs inflammatory marker expression in regenerating rat skeletal muscles after injury. Abstract
Lynch, Gordon S	The University of Melbourne	04/19/2013	2.16	Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society Intramuscular administration of PEGylated IGF-I improves skeletal muscle regeneration after myotoxic injury. Abstract
Delafontaine, Patrice	Tulane University School of Medicine	11/12/2012	2.08	Clinical interventions in aging Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients. Abstract